-
PathAI Diagnostics' test allows for the histologic scoring and staging of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). It will be announced at the American College of Gastroenterology 2023 Meeting October 20-25 in Vancouver, Canada.
Oct 18, 2023
-
Partnership Enables Healthcare Organizations to Leverage Unique Risk Advisory Services and Purpose-Built Workflow Automation to Maximize Cyber Risk Reduction
Oct 17, 2023
-
Oct 18, 2023
-
BOC Sciences will attend "TIDES Europe: Oligonucleotide & Peptide Therapeutics", delivered as a hybrid event from 30 Oct - 1 Nov 2023, in Amsterdam, NL. Its high-yield nucleosides & nucleotides, as well as a newly launched XDC platform, will be exhibited in front of the industry.
Oct 18, 2023
-
Oct 3, 2023
-
Biotium has announced the launch of its breakthrough BactoView™ Dead Stains and BactoView™ Viability Kits.
Oct 17, 2023
-
Oct 18, 2023
-
Oct 10, 2023
-
Addition brings together synchronized experts to offer comprehensive predictive analytics, data visualization and AI-driven end-to-end solutions for life sciences, government and non-profit organizations
Oct 17, 2023
-
Oct 15, 2023
-
Oct 14, 2023
-
First Health Advisory recently welcomed Rick LeMay as its Executive Vice President of Enterprise Security & Technology to help advance the company's mission of providing digital health risk assurance to healthcare organizations.
Oct 9, 2023
-
WCG has now achieved ISO 9001 certification for its Institutional Biosafety Committee (IBC) services as well as its Institutional Review Board (IRB) services, emphasizing its commitment to excellence in quality management across ethical review.
Oct 9, 2023
-
Biopharma PEG announces a robust inventory of monodispersed PEGs, including mPEG36-NH2, NH2-PEG24-COOH, and more, catering to the pharmaceutical industry's diverse needs. These high-purity products, certified under EXCIPACT GMP standards with purity exceeding 95%, are ideal for ADCs, PROTACs, and drug delivery systems, reinforcing Biopharma PEG as a top-tier provider for pharmaceutical researchers and developers.
Oct 15, 2023
-
Huateng Pharma, a leading pharmaceutical ingredient manufacturer, has introduced a new product line, Gastrointestinal API Intermediates, featuring Fexuprazan and Vonoprazan Intermediates. These intermediates are designed to meet the increasing demand for high-quality solutions in gastrointestinal therapy. The products are available in both GMP and Non-GMP grades, boasting exceptional purity to facilitate the production of top-tier pharmaceuticals.
Oct 15, 2023
-
Specialist Biometrics CRO, Veramed, today announced the acquisition of Boston-based data management, biostatistics and medical writing company, CTDS.
Oct 4, 2023
-
Collaboration aims to advance the use of adjunct diagnostics in digital pathology for accelerated, democratized precision medicine in cancer care
Oct 3, 2023
-
Oct 2, 2023
-
Expert staff will be on hand at the conference to discuss how BioIVT can support CGT research from discovery and development to commercialization.
Oct 2, 2023
-
10 Baylor Genetics abstracts accepted for presentation at three top genetic conferences, focusing on topics ranging from Whole Genome and Whole Exome Sequencing to Carrier Screening and Non-Invasive Prenatal Testing
Oct 1, 2023